Drugs / low-volume PEG -ascorbic acid
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01603654 Comparator | Jan → Jun 2011 | — | ASST Fatebenefratelli Sacco | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | low-volume PEG -ascorbic acid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01603654 ↗ |
| Known as | PEG+ASC | “low-volume PEG -ascorbic acid (PEG+ASC)” NCT01603654 ↗ |
| Route | Oral | “It is supplied as a powder for oral use” NCT01603654 ↗ |